Cyclophosphamide Capsules and Ranexa
Determining the interaction of Cyclophosphamide Capsules and Ranexa and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Professional:Coadministration with ranolazine may theoretically alter the metabolism of drugs that are substrates of CYP450 2B6. Clinical data are lacking and the clinical significance is unknown; however, caution is advisable during concomitant use.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Generic Name: cyclophosphamide
Brand name: Cytoxan, Neosar, Cytoxan Lyophilized
Synonyms: Cyclophosphamide (oral and injection), Cyclophosphamide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cyclophosphamide Capsules-Ranibizumab
- Cyclophosphamide Capsules-Ranibizumab Intraocular
- Cyclophosphamide Capsules-Ranibizumab ophthalmic
- Cyclophosphamide Capsules-Ranitidine
- Cyclophosphamide Capsules-Ranitidine Capsule
- Cyclophosphamide Capsules-Ranitidine Hydrochloride
- Ranexa-Cyclophosphamide Injection
- Ranexa-Cyclophosphamide oral and injection
- Ranexa-Cyclophosphamide Oral, Intravenous
- Ranexa-Cyclophosphamide Tablets
- Ranexa-Cycloserine
- Ranexa-Cycloserine Capsules